Status:
COMPLETED
Biomarkers of Muscle Anabolism (MK-0000-082)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Muscle Anabolism
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
This study will evaluate the ability of comparative proteomics to identify early biomarkers of muscle anabolism.
Eligibility Criteria
Inclusion
- subject is a healthy male between 18 and 40 years old
- subject's weight is stable over the past 3 months
- subject agrees to refrain from consuming alcohol during study
- subject agrees to consume no caffeine while in the CRU
- subject agrees to follow meat-free diet
- subject is willing to avoid strenuous activity
- subject has been a nonsmoker for at least 6 months
Exclusion
- subject is a regular user of illicit drugs
- subject has taken androgenic steroids in the past 12 months
- subject has participated in sports events, resistance training, or moderate to heavy endurance training in the past month
- subject has prostate cancer
- subject has HIV and/or hepatitis B or C
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00812396
Start Date
November 1 2007
End Date
February 1 2008
Last Update
January 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.